Literature DB >> 6267167

Latency in vitro using irradiated herpes simplex virus.

Y Nishiyama, F Rapp.   

Abstract

Human embryonic fibroblasts infected with u.v.-irradiated herpes simplex virus type 2 (HSV-2, strain 186) and maintained at 40.5 degrees C did not yield detectable virus. Virus synthesis was induced by temperature shift-down to 36.5 degrees C. The induced virus grew very poorly and was inactivated very rapidly at 40.5 degrees C. Non-irradiated virus failed to establish latency at 40.5 degrees C in infected cells. Enhanced reactivation of HSV-2 was observed when latently infected cultures were superinfected with human cytomegalovirus (HCMV) or irradiated with a small dose of u.v. light at the time of temperature shift-down. HCMV did not enhance synthesis of HSV-2 during a normal growth cycle but did enhance synthesis of u.v.-irradiated HSV-2. These observations suggest that in this in vitro latency system, some HSV genomes damaged by u.v. irradiation were maintained in a non-replicating state without being destroyed or significantly repaired.

Entities:  

Mesh:

Year:  1981        PMID: 6267167     DOI: 10.1099/0022-1317-52-1-113

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

Review 1.  Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.

Authors:  D Pavan-Langston
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  Role of the nuclear matrix in the growth of herpes simplex virus type 2.

Authors:  Y Tsutsui; Y Nishiyama; S Yoshida; K Maeno; M Hoshino
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Heat(40 degrees C)-induced polypeptides in human embryonic fibroblasts.

Authors:  Y Nishiyama; Y Tsutsui; T Tsurumi; H Aoki; Y Ito; K Maeno
Journal:  Experientia       Date:  1983-04-15

4.  Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1.

Authors:  Robert McMahon; Derek Walsh
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.